A Universal, Continuous Assay for SAM-dependent Methyltransferases

Angew Chem Int Ed Engl. 2023 Dec 18;62(51):e202313912. doi: 10.1002/anie.202313912. Epub 2023 Nov 20.

Abstract

Enzyme-catalyzed late-stage functionalization (LSF), such as methylation of drug molecules and lead structures, enables direct access to more potent active pharmaceutical ingredients (API). S-adenosyl-l-methionine-dependent methyltransferases (MTs) can play a key role in the development of new APIs, as they catalyze the chemo- and regioselective methylation of O-, N-, S- and C-atoms, being superior to traditional chemical routes. To identify suitable MTs, we developed a continuous fluorescence-based, high-throughput assay for SAM-dependent methyltransferases, which facilitates screening using E. coli cell lysates. This assay involves two enzymatic steps for the conversion of S-adenosyl-l-homocysteine into H2 S to result in a selective fluorescence readout via reduction of an azidocoumarin sulfide probe. Investigation of two O-MTs and an N-MT confirmed that this assay is suitable for the determination of methyltransferase activity in E. coli cell lysates.

Keywords: Enzyme Catalysis; High-Throughput Screening; Homocysteine; Hydrogen Sulfide; SAM-Dependent Methyltransferases.

MeSH terms

  • Escherichia coli* / metabolism
  • Methionine
  • Methylation
  • Methyltransferases* / metabolism
  • S-Adenosylmethionine / chemistry

Substances

  • Methyltransferases
  • S-Adenosylmethionine
  • Methionine

Grants and funding